Search Results - "Hoyos, Valentina"
-
1
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
Published in Frontiers in immunology (03-03-2022)“…To redirect T cells against tumor cells, T cells can be engineered to express cancer-antigen specific T cell receptors (TCRs), generating products known as…”
Get full text
Journal Article -
2
Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Breast Cancer: Looking beyond Tumoral PD-L1
Published in Biomedicines (08-12-2021)“…Immune checkpoint inhibitors utilize the immune system to kill cancer cells and are now widely applied across numerous malignancies. Pembrolizumab has two…”
Get full text
Journal Article -
3
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
Published in Journal for immunotherapy of cancer (01-11-2021)“…BackgroundSuccessful targeting of solid tumors such as breast cancer (BC) using chimeric antigen receptor (CAR) T cells has proven challenging, largely…”
Get full text
Journal Article -
4
CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation
Published in Journal for immunotherapy of cancer (10-05-2018)“…The adoptive transfer of T cells redirected to tumor via chimeric antigen receptors (CARs) has produced clinical benefits for the treatment of hematologic…”
Get full text
Journal Article -
5
Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
Published in Clinical cancer research (15-09-2009)“…Purpose: Genetic engineering of human T lymphocytes to express tumor-directed chimeric antigen receptors (CAR) can produce antitumor effector cells that bypass…”
Get full text
Journal Article -
6
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer
Published in Therapeutic advances in medical oncology (2022)“…Purpose: Adoptively transferred, ex vivo expanded multi-antigen-targeted T cells (multiTAA-T) represent a new, potentially effective, and nontoxic therapeutic…”
Get full text
Journal Article -
7
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas
Published in Journal for immunotherapy of cancer (01-05-2021)“…BackgroundPediatric high-grade gliomas (pHGGs) are among the most common and incurable malignant neoplasms of childhood. Despite aggressive, multimodal…”
Get full text
Journal Article -
8
Genetic modification of human T lymphocytes for the treatment of hematologic malignancies
Published in Haematologica (Roma) (01-11-2012)“…Modern chemotherapy regimens and supportive care have produced remarkable improvements in the overall survival of patients with hematologic malignancies…”
Get full text
Journal Article -
9
Lumpectomy followed by radiation improves survival in HER2 positive and triple‐negative breast cancer with high tumor‐infiltrating lymphocytes compared to mastectomy alone
Published in Cancer medicine (Malden, MA) (01-07-2021)“…Objective The goal was to compare the 5‐year DFS and 5‐year OS in patients with early‐stage human epidermal growth factor receptor 2 breast cancer (HER2+ BC)…”
Get full text
Journal Article -
10
Dose-reduced trastuzumab deruxtecan can be safely used in liver failure and active leptomeningeal metastases
Published in Current problems in cancer. Case reports (01-12-2020)“…Trastuzumab deruxtecan has been shown to have responses in heavily pretreated patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic…”
Get full text
Journal Article -
11
Multiple mechanisms determine the sensitivity of human-induced pluripotent stem cells to the inducible caspase-9 safety switch
Published in Molecular therapy. Methods & clinical development (01-01-2016)“…Expression of the inducible caspase-9 (iC9) suicide gene is one of the most appealing safety strategies for cell therapy and has been applied for human-induced…”
Get full text
Journal Article -
12
The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies
Published in Blood (29-09-2016)“…The treatment of multiple myeloma has evolved significantly over the last decades from primarily alkylator-based chemotherapeutic agents with minimal efficacy…”
Get full text
Journal Article -
13
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
Published in Nature medicine (01-05-2015)“…Gianpietro Dotti and colleagues report that CAR-T cells expressing heparanase to degrade the extracellular matrix may enhance their infiltration of and effects…”
Get full text
Journal Article -
14
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors
Published in Cancer research (Chicago, Ill.) (15-09-2014)“…The clinical efficacy of chimeric antigen receptor (CAR)-redirected T cells remains marginal in solid tumors compared with leukemias. Failures have been…”
Get full text
Journal Article -
15
Crisis en el sistema de fuentes del derecho internacional: el SOFT LAW en el derecho penal internacional y el derecho penal colombiano
Published in Derecho penal y criminología (01-01-2022)“…El soft law es una fuente del derecho internacional que influye en el derecho penal internacional y en el sistema penal colombiano. La evolución del derecho…”
Get full text
Journal Article -
16
Abstract P2-08-14: Effect of markers of systemic inflammation on tumor infiltrating lymphocytes in patients with non-metastatic triple negative and HER2+ breast cancer: A single center retrospective study
Published in Cancer research (Chicago, Ill.) (15-02-2022)“…Abstract Background: Tumor infiltrating lymphocytes (TILs) are increasingly being recognized as a vital component of the tumor immune microenvironment. TILs…”
Get full text
Journal Article -
17
An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells
Published in Molecular therapy (01-09-2015)“…Human induced pluripotent stem cells (hiPSC) hold promise for regenerative therapies, though there are several safety concerns including the risk of oncogenic…”
Get full text
Journal Article -
18
Frequency of coprescription and potential risk of bronchospasm in Colombian patients users of topical antiglaucomatous betablockers and bronchodilators
Published in Vitae (Medellín) (21-07-2014)“…Background: Cardiovascular and respiratory effects of adrenergic agonists used in diseases like chronic obstructive pulmonary disease (COPD), and β-blockers…”
Get full text
Journal Article -
19
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity
Published in Molecular therapy (05-05-2021)“…The immunosuppressive tumor microenvironment (TME) is a formidable barrier to the success of adoptive cell therapies for solid tumors. Oncolytic immunotherapy…”
Get full text
Journal Article -
20
Toxicidad sistemica por anestesicos locales
Published in C.E.S. medicina (01-01-2014)“…Los anestésicos locales son medicamentos de uso generalizado y, aunque se consideran seguros, ocasionalmente pueden producir toxicidad con alteración del…”
Get full text
Journal Article